Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 22:13:960319.
doi: 10.3389/fmicb.2022.960319. eCollection 2022.

Antimicrobial therapy in complicated rhinosinusitis

Simion-Antonie Catrinel Beatrice  1   2 , Bejenaru Paula Luiza  1   2 , Popescu Bogdan  1   2 , Berteșteanu Gloria Simona  2   3 , Condeescu-Cojocărița Mihnea  1   2 , Cîrstea Anca Ionela  1 , Diaconu Teodora Elena  1 , Taher Bianca Petra  1   2 , Rujan Simona-Andreea  1   2 , Oașă Irina Doinița  1 , Berteșteanu Șerban Vifor Gabriel  1   2 , Grigore Raluca  1   2
Affiliations

Antimicrobial therapy in complicated rhinosinusitis

Simion-Antonie Catrinel Beatrice et al. Front Microbiol. .

Abstract

Introduction: Complicated rhinosinusitis is a rare but life-threatening pathology that requires both medical and surgical treatment as soon as possible. The spread of the infection from the paranasal sinuses affects, most often, the orbit, patients presenting diplopia, preseptal cellulitis, orbital cellulitis, or even blindness alongside exteriorization of puss from the middle meatus and nasal obstruction.

Materials and methods: We carried out a retrospective review of 32 patients that were diagnosed in our clinic with complicated rhinosinusitis from 2015 to 2022. All the patients received at least one intravenous antibiotic, and some also received antifungal drugs. All patients underwent surgery, either endoscopically or combined approach. Nasal washout or nasal swabs during surgery were sent for laboratory examination in all patients, and we studied the microbial etiology in these extensive infections. A database with all the information regarding demographic and medical data was established.

Results: 78% of the patients were male, with a mean age of 50.55. A wide range of antibiotics were used, while some patients, diagnosed with mucormycosis also received antifungal drugs. The mean hospitalization period was 12 days. We correlated the type of antibiotic with the hospitalization period and the outcome but also the degree of involvement of the orbit and the microbial strains identified.

Discussion: The management of patients with complicated rhinosinusitis is complex and dynamic and it must be tailored to every patient, after an interdisciplinary meeting with the infectious disease specialist, ophthalmologist, and rhinologist. The microbial strains that produce such important infections are sometimes multi-resistant or combined, patients usually already had followed a course of antibiotics at home, and choosing the right treatment is sometimes challenging.

Keywords: antibiotics; antimicrobial; complications; orbital; rhinosinusitis; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Correlation between the symptomatic days prior hospitalization and age.
Figure 2
Figure 2
Signs of complicated rhinosinusitis at presentation.
Figure 3
Figure 3
Endoscopic aspect of mucormycosis
Figure 4
Figure 4
CT scan in sagittal view.
Figure 5
Figure 5
Hospitalization days by approach.
Figure 6
Figure 6
Distribution of bacterial strains isolated from the nasal washouts.
See this image and copyright information in PMC

References

    1. Anniko M., Bernal-Sprekelsen M., Bonkowsky V., Bradley P. J., Iurato S. (2010). Otorhinolaryngology, Head and Neck Surgery (European Manual of Medicine). Berlin: Springer.
    1. Anon J. B., Jacobs M. R., Poole M. D., Ambrose P. G., Benninger M. S., Hadley J. A., et al. . (2004). Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol. Neck Surg. 130, 1–45. doi: 10.1016/j.otohns.2003.12.003, PMID: - DOI - PMC - PubMed
    1. Chow A. W., Benninger M. S., Brook I., Brozek J. L., Goldstein E. J. C., Hicks L. A., et al. . (2012). IDSA clinical practice guideline for acute bacterial Rhinosinusitis in children and adults. Clin. Infect. Dis. 54, e72–e112. doi: 10.1093/cid/cis370, PMID: - DOI - PubMed
    1. Cornely O. A., Alastruey-Izquierdo A., Arenz D., Chen S. C. A., Dannaoui E., Hochhegger B., et al. . (2019). Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the mycoses study group education and research consortium. Lancet infect dis [internet]. 19, e405–e421. doi: 10.1016/S1473-3099, - DOI - PMC - PubMed
    1. Flint Paul, Haughey Bruce, Lund Valerie, Robbins K., Regan Thomas J., Lesperance Marci, et al.. (2020). Cummings Otolaryngology, Head and Neck Surgery. 7th Edn., Philadelphia, PA: Elsevier.

LinkOut - more resources